Rebecca Byam
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rebecca Byam
Rebecca Byam is recorded as CFO at HCW Biologics Inc. (HCWB). The proxy statement of HCW Biologics Inc. reports total compensation of $309,309 for Rebecca Byam in fiscal 2025, including a base salary of $297,412. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at HCW Biologics Inc.
Other people whose current roles at this company are on record from its filings.
- Hing C. Wong CEO, Board Member
- Gary Winer Board Member
- Lisa Giles Board Member
- Lisa M. Giles Board Member
- Rick S. Greene Board Member
- Scott T. Garrett Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | HCW Biologics Inc. (HCWB) | Chief Financial Officer | $297,412 | $309,309 |
| 2024 | HCW Biologics Inc. (HCWB) | Chief Financial Officer | $143,496 | $154,236 |
| 2023 | HCW Biologics Inc. (HCWB) | Chief Financial Officer | $288,750 | $330,300 |
| 2022 | HCW Biologics Inc. (HCWB) | Chief Financial Officer | $285,048 | $297,080 |
| 2021 | HCW Biologics Inc. (HCWB) | Chief Financial Officer | $275,000 | $982,140 |
Recent activity
No call appearances or filed executive changes recorded yet.